V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004292 | 290003156 | 1.63 | 64.2 | Adjuvant (A) | 2015-01-20 | 2015-02-14 | Cisplatin+Gemcitabine (gallbladder) | Y | Y | 290020925 | CAPECITABINE + RT |
| 290004293 | 290003157 | null | 77.5 | Disease modification (D) | 2017-08-26 | 2017-08-29 | null | 02 | N | 290020928 | CAPECITABINE |
| 290004294 | 290003158 | 1.78 | 61.7 | Palliative (P) | 2014-11-17 | 2014-12-01 | Cetuximab + Irinotecan (Cycle 1) | N | N | 290020929 | EOX |
| 290004295 | 290003159 | 1.79 | 61.7 | Palliative (P) | 2015-10-19 | 2015-10-20 | FCiSt | N | N | 290020931 | GEMCITABINE + PACLITAXEL |
| 290004296 | 290003160 | 1.73 | 62.7 | Palliative (P) | 2015-05-31 | 2015-05-31 | CETUXIMAB + CISPLATIN + FU | N | N | 290020932 | CARBOPLATIN |
| 290004297 | 290003161 | 1.78 | 58.5 | Palliative (P) | 2017-02-08 | 2017-02-23 | Carboplatin AUC 6 - 10 | N | N | 290020933 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004298 | 290006458 | 1.61 | 0 | Neo-adjuvant (N) | 2017-10-31 | 2017-10-31 | MCX | 02 | N | 290020935 | CARBOPLATIN |
| 290004299 | 290003162 | 1.6 | 46 | Adjuvant (A) | 2013-10-25 | 2014-10-27 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 290020936 | CVP R |
| 290004300 | 290003163 | 1.78 | null | Neo-adjuvant (N) | 2016-12-08 | 2016-12-11 | Capecitabine 35days + RT | N | N | 290020937 | RITUXIMAB |
| 290004301 | 290003164 | null | null | Palliative (P) | 2014-03-11 | 2014-03-24 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | 290020938 | CETUXIMAB + CISPLATIN + FU |
| 290004302 | 290003165 | 1.8 | 116 | Adjuvant (A) | null | 2013-08-16 | Cetuximab + Radiotherapy Load | N | N | 290020941 | CAPECITABINE + RT |
| 290004303 | 290003166 | 1.7 | null | Curative (C) | 2017-08-21 | 2017-08-30 | LANREOTIDE | N | Y | 290020942 | CAPECITABINE + CISPLATIN |
| 290004304 | 290003167 | 0 | 96.8 | null | 2016-03-14 | 2016-05-24 | CAPECITABINE + CARBOPLATIN | N | N | 290020946 | IPILIMUMAB |
| 290004305 | 290003168 | null | 79.9 | Palliative (P) | null | 2013-09-25 | Fluorouricil + Folonic Acid (MdG) | N | N | 290020947 | MCX |
| 290004306 | 290006459 | 1.7 | 93.8 | Palliative (P) | 2015-05-08 | 2015-05-08 | Cytarabine Low Dose | 02 | N | 290020948 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004307 | 290006459 | 1.7 | 71 | Palliative (P) | 2013-09-21 | 2014-07-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290020948 | LANREOTIDE |
| 290004308 | 290003169 | null | 68.6 | Palliative (P) | 2015-12-15 | 2015-12-15 | ECF | Y | N | 290020951 | CAPECITABINE + STREPTOZOCIN |
| 290004309 | 290003170 | 1.62 | 76.6 | Curative (C) | 2016-06-29 | 2016-07-25 | CAPECITABINE + RT | 02 | Y | 290020954 | CETUXIMAB + RT |
| 290004310 | 290003171 | 1.75 | 96.2 | Palliative (P) | 2014-11-25 | 2014-11-25 | Cetuximab + Radiotherapy Load | 2 | N | 290020957 | CARBO + FLUOROURACIL |
| 290004311 | 290003172 | 1.69 | 63 | Palliative (P) | 2013-12-09 | 2013-12-09 | GEMCITABINE | 02 | N | 290020958 | CHOP R |
| 290004312 | 290003173 | 1.63 | 81 | Curative (C) | 2016-11-21 | 2016-12-05 | LANREOTIDE | N | N | 290020960 | LANREOTIDE |
| 290004313 | 290003174 | null | 62 | Adjuvant (A) | 2013-12-30 | 2014-01-27 | Hydroxycarbamide | N | Y | 290020961 | DOXORUBICIN + OLARATUMAB |
| 290004314 | 290006460 | 1.53 | 71.85 | Palliative (P) | 2016-11-06 | 2016-11-24 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290020963 | Y-90 |
| 290004315 | 290007729 | 1.6 | 66.2 | Curative (C) | null | 2017-11-29 | CISPLATIN + FLUOROURACIL | N | N | 290020965 | ECX |
| 290004316 | 290003175 | 1.61 | null | Curative (C) | null | 2017-05-10 | CARBOPLATIN + RT | N | N | 290020967 | CAPECITABINE |
| 290004317 | 290003175 | 1.5 | 55.4 | Curative (C) | 2015-10-26 | 2015-10-29 | Fluorouracil 96hr infusion+R(4g/m2) | N | N | 290020967 | CARBOPLATIN + RT |
| 290004318 | 290003175 | 1.54 | 54.8 | Disease modification (D) | 2017-05-17 | 2017-05-17 | CETUXIMAB + IRINOTECAN + MDG | N | N | 290020967 | CAPECITABINE |
| 290004319 | 290003176 | null | 50.4 | Curative (C) | 2016-06-01 | 2016-07-18 | Carboplatin AUC 2 - 5 | N | N | 290020970 | CETUXIMAB + RT |
| 290004320 | 290003177 | 1.68 | 83 | Palliative (P) | 2013-12-15 | 2014-07-06 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020971 | CAPECITABINE |
| 290004321 | 290003178 | 1.56 | 56 | Palliative (P) | 2015-08-07 | 2015-08-17 | Fluorouracil 96hr infusion+R(4g/m2) | 2 | N | 290020972 | CARBOPLATIN + ETOPOSIDE |
| 290004322 | 290003179 | 1.79 | 78 | Adjuvant (A) | 2017-07-20 | 2017-07-20 | Cisplatin +Fluorouracil (3 wk) | 2 | Y | 290020974 | CAPECITABINE + CISPLATIN |
| 290004323 | 290003180 | 1.82 | 0 | null | 2016-08-27 | 2016-09-09 | BORTEZOMIB + THALIDOMIDE | 02 | N | 290020977 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004324 | 290003181 | 1.65 | 48.4 | Curative (C) | 2016-12-24 | 2016-12-31 | Cetuximab 7 day (Cycle 1) | 2 | N | 290020978 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004325 | 290006462 | 1.59 | 37.4 | Palliative (P) | null | 2016-12-04 | LANREOTIDE | null | null | 290020979 | LANREOTIDE |
| 290004326 | 290003182 | 1.7 | 61 | null | 2014-09-02 | 2014-09-05 | Cetuximab + FLUOROURACIL + FOLINIC ACID + OXALIPLATIN | N | N | 290020980 | OCTREOTIDE |
| 290004327 | 290003183 | 1.58 | 98 | null | 2013-04-04 | 2013-04-04 | Carboplatin AUC 2 - 5 | N | N | 290020982 | LANREOTIDE |
| 290004328 | 290003183 | 1.6 | 68.6 | Palliative (P) | 2014-10-12 | 2014-10-12 | ECX | N | N | 290020982 | CETUXIMAB |
| 290004329 | 290007731 | 1.75 | 75.6 | Palliative (P) | 2017-06-08 | 2017-06-19 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020984 | LANREOTIDE |
| 290004330 | 290003184 | 1.72 | 86.4 | Palliative (P) | 2013-07-13 | 2013-07-25 | Y-90 | N | N | 290020985 | CAPECITABINE + RT |
| 290004331 | 290003185 | null | 108 | Curative (C) | 2017-10-07 | 2017-10-20 | ECX | N | Y | 290020986 | CAP |
| 290004332 | 290003185 | 1.78 | 62.35 | Palliative (P) | 2013-10-22 | 2013-11-09 | CISPLATIN + FLUOROURACIL | 02 | N | 290020986 | CISPLATIN + ETOPOSIDE |
| 290004333 | 290003186 | 1.64 | 59.8 | Curative (C) | 2016-09-23 | 2016-10-07 | Capecitabine 35days + RT | N | Y | 290020991 | PLATO TRIAL |
| 290004334 | 290003187 | 1.74 | 83.3 | Palliative (P) | 2018-12-18 | 2018-12-21 | EOX | N | N | 290020995 | CARBOPLATIN + ETOPOSIDE |
| 290004335 | 290003188 | 1.69 | 83 | Palliative (P) | 2013-07-01 | 2013-07-26 | Azacitidine | N | N | 290020997 | TRIAL |
| 290004336 | 290003189 | 1.5 | 78 | Palliative (P) | 2017-09-01 | 2017-09-07 | Capecitabine + Streptozocin | 2 | N | 290021001 | CAPECITABINE + IRINOTECAN |
| 290004337 | 290003190 | null | 65 | null | 2013-11-20 | 2013-12-08 | Capecitabine | null | Y | 290021002 | IRINOTECAN |
| 290004338 | 290003190 | null | 68 | Palliative (P) | 2016-02-14 | 2016-02-20 | CHOP R - 21 days | 02 | N | 290021002 | CAPECITABINE |
| 290004339 | 290003190 | 1.88 | null | Palliative (P) | null | 2016-12-28 | CARBOPLATIN + ETOPOSIDE | null | Y | 290021002 | CAPECITABINE + CISPLATIN |
| 290004340 | 290003191 | 1.79 | 70.2 | Curative (C) | 2016-10-25 | 2016-11-15 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 01 | Y | 290021009 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 290004341 | 290003192 | 1.53 | 53 | Palliative (P) | 2016-04-13 | 2016-04-17 | CISPLATIN + ETOPOSIDE | 02 | N | 290021010 | GEMCITABINE |